Tumorigenesis: Transcriptional elongation and cancer
- 1 August 1996
- journal article
- review article
- Published by Elsevier in Current Biology
- Vol. 6 (8) , 943-944
- https://doi.org/10.1016/s0960-9822(02)00633-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- An RNA Polymerase II Elongation Factor Encoded by the Human ELL GeneScience, 1996
- Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density.Proceedings of the National Academy of Sciences, 1996
- Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and CScience, 1995
- Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase IIScience, 1995
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995
- Regulation of transcriptional elongation by RNA polymerase IICurrent Opinion in Genetics & Development, 1995
- Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.Genes & Development, 1995
- Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.Proceedings of the National Academy of Sciences, 1994
- Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing.Genes & Development, 1993
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993